Addressing the Global Burden of Disease

NUR6400 Role Development in Family Practice: Clinical
Integration
Signature Assignment
Understanding the role technology plays in advanced primary care
to vulnerable populations is vital to ensure proper and timely
diagnosis and treatment to improve healthcare outcomes for the
patient. The purpose of this assignment is to evaluate one global
burden of disease OR risk factor in the family population
(pediatric, adult, or geriatric) and explore one current evidence-
based technology use that can offer improvement of outcomes and
access to the population chosen.
This assignment will focus on the following course student
learning outcomes (CSLO):
1. Generate knowledge from clinical practice to improve
practice and patient outcomes (EOPSLO# 4, 9).
2. Leads practice inquiry, individually or in partnership with
others (EOPSLO# 2, 3, 4, 7).
3. Translates research and other forms of knowledge to
improve practice processes and outcomes (EOPSLO# 9).
4. Evaluate the relationships among access, cost, quality, and
safety and their influence on healthcare (EOPSLO# 3, 6, 9).
5. Collaborates in planning for transitions across the continuum
of care (EOPSLO# 2, 7).
6. Integrates ethical principles in decision-making (EOPSLO#
6,9).
7. Integrates appropriate technologies for knowledge
management to improve healthcare (EOPSLO# 5).
8. Evaluate the effectiveness of the plan of care for the family,

as well as the individual, and implement changes (EOPSLO#
8).
Instructions: Please choose one global burden of disease and one
population (adult, pediatric, or geriatric). Once the population is
chosen, find one evidence-based technology to help support the
Improvement of outcomes in the global burden of disease chosen.
You are to write a three-to-five-page paper in APA format 7th
edition with the following sections and level 2 headings:
Introduction
-Brief overview of the health of the population chosen
-Introduce the global burden of disease OR risk factor chosen
-Importance of improving the condition and its impact on quality
of life

Global Burden of Disease Condition/Risk Factor
-Describe the disease OR risk factor chosen
-What signs/symptoms are identified in the patient that can be
found?
-How is it diagnosed and treated?
Technology and Healthcare
-Describe the paradigm shift in healthcare related to technology
-Elaborate how technology can improve health outcomes in your
population
Chosen Evidence-Based Technology Use in Disease or Risk
Factor
-Describe and summarize the evidence-based technology
identified that has been shown to improve the condition or Risk
Factor for your patient population chosen.
-Compare and contrast the positives and negatives of using this
technology use chosen.
Conclusion
-Recap points discussed in the paper
-Importance of advancements in technology
Optional Resources:
https/www.thelancet.com/gbd/summaries
https://www.healthdata.org/research-analysis/librarywhat-global-burden-disease-gbd

Addressing the Global Burden of Disease

Role of Technology in Addressing the Global Burden of Disease: Focus on Pediatric Asthma

Introduction

In this paper, we will explore the intersection of technology and healthcare in addressing pediatric asthma, a significant global burden of disease affecting children worldwide. Pediatric asthma poses a substantial challenge due to its prevalence, impact on quality of life, and healthcare costs. Leveraging evidence-based technology is crucial to improving outcomes for children suffering from asthma.

Global Burden of Disease Condition: Pediatric Asthma

Pediatric asthma is a chronic respiratory condition characterized by airway inflammation and bronchial hyperresponsiveness, leading to recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. Diagnosis typically involves a combination of clinical history, physical examination, and pulmonary function tests. Treatment strategies include pharmacotherapy with inhaled corticosteroids, bronchodilators, and education on trigger avoidance and proper inhaler technique.

Technology and Healthcare Paradigm Shift

In recent years, there has been a paradigm shift in healthcare towards the integration of technology to improve patient outcomes. Advances in telemedicine, digital health platforms, and wearable devices offer novel opportunities to monitor and manage pediatric asthma more effectively. These technologies facilitate remote monitoring of symptoms, medication adherence, and environmental triggers, allowing for timely interventions and personalized treatment plans.

Evidence-Based Technology Use in Pediatric Asthma: Smart Inhaler Devices

One promising technology in pediatric asthma management is the smart inhaler device. These devices are equipped with sensors that track inhaler usage, monitor medication adherence, and provide real-time feedback to patients and healthcare providers. Studies have demonstrated that smart inhalers improve adherence to controller medications, reduce exacerbations, and enhance asthma control in children.

Positives:

  • Improved medication adherence: Smart inhalers remind patients to take their medications on time and provide visual feedback on inhaler technique.
  • Remote monitoring: Healthcare providers can remotely monitor patients’ inhaler usage and adjust treatment plans accordingly, leading to more proactive management.
  • Personalized feedback: Smart inhalers offer personalized insights into asthma triggers and patterns, empowering patients to better manage their condition.

Negatives:

  • Cost: Smart inhalers may be expensive, limiting access for some patients, particularly in low-resource settings.
  • Data privacy concerns: Collecting and transmitting sensitive health data via smart inhalers raises privacy and security concerns that need to be addressed.

Conclusion

In conclusion, leveraging evidence-based technology such as smart inhaler devices holds immense promise in improving outcomes for children with pediatric asthma. By embracing these innovations, healthcare providers can enhance disease monitoring, optimize treatment strategies, and ultimately improve the quality of life for pediatric asthma patients worldwide.

Scroll to Top